The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Biolife Solutions Inc (NASDAQ: BLFS) closed at $27.73 in the last session, down -3.55% from day before closing price of $28.75. In other words, the price has decreased by -$3.55 from its previous closing price. On the day, 0.51 million shares were traded. BLFS stock price reached its highest trading level at $29.04 during the session, while it also had its lowest trading level at $27.68.
Ratios:
We take a closer look at BLFS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 113.06. For the most recent quarter (mrq), Quick Ratio is recorded 3.45 and its Current Ratio is at 4.43. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
On September 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $29.
On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $22.Jefferies initiated its Buy rating on April 04, 2024, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 16 ’25 when GOSWAMI JOYDEEP bought 9,000 shares for $30.99 per share.
Casdin Partners Master Fund, L bought 750,000 shares of BLFS for $21,410,325 on Oct 15 ’25. On Oct 09 ’25, another insider, Wichterman Troy, who serves as the Chief Financial Officer of the company, sold 833 shares for $27.36 each. As a result, the insider received 22,791 and left with 183,353 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLFS now has a Market Capitalization of 1328412928 and an Enterprise Value of 1270461952. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.94 while its Price-to-Book (P/B) ratio in mrq is 3.82. Its current Enterprise Value per Revenue stands at 13.592 whereas that against EBITDA is -1016.37.
Stock Price History:
The Beta on a monthly basis for BLFS is 1.95, which has changed by 0.17350829 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, BLFS has reached a high of $29.55, while it has fallen to a 52-week low of $19.10. The 50-Day Moving Average of the stock is 8.51%, while the 200-Day Moving Average is calculated to be 13.82%.
Shares Statistics:
According to the various share statistics, BLFS traded on average about 467.48K shares per day over the past 3-months and 458290 shares per day over the past 10 days. A total of 47.85M shares are outstanding, with a floating share count of 46.23M. Insiders hold about 3.49% of the company’s shares, while institutions hold 101.94% stake in the company. Shares short for BLFS as of 1759190400 were 3688709 with a Short Ratio of 7.89, compared to 1756425600 on 3944511. Therefore, it implies a Short% of Shares Outstanding of 3688709 and a Short% of Float of 10.9.
Earnings Estimates
Its stock is currently analyzed by 5.0 different market analysts. The consensus estimate for the next quarter is $0.01, with high estimates of $0.03 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.1 and -$0.06 for the fiscal current year, implying an average EPS of $0.04. EPS for the following year is $0.15, with 4.0 analysts recommending between $0.18 and $0.1.
Revenue Estimates
According to 10 analysts,. The current quarter’s revenue is expected to be $25.69M. It ranges from a high estimate of $26M to a low estimate of $25.09M. As of. The current estimate, Biolife Solutions Inc’s year-ago sales were $30.57MFor the next quarter, 10 analysts are estimating revenue of $26.41M. There is a high estimate of $27.2M for the next quarter, whereas the lowest estimate is $24.9M.
A total of 10 analysts have provided revenue estimates for BLFS’s current fiscal year. The highest revenue estimate was $102.36M, while the lowest revenue estimate was $99.8M, resulting in an average revenue estimate of $101.3M. In the same quarter a year ago, actual revenue was $82.25MBased on 9 analysts’ estimates, the company’s revenue will be $116.32M in the next fiscal year. The high estimate is $120.9M and the low estimate is $112M.
